4.5 Article

Fetal autonomic brain age scores, segmented heart rate variability analysis, and traditional short term variability

Journal

FRONTIERS IN HUMAN NEUROSCIENCE
Volume 8, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnhum.2014.00948

Keywords

prenatal diagnosis; fetal autonomic brain age; magnetocardiography; cardiotocography

Funding

  1. German Research Foundation (Deutsche Forschungsgemeinschaft) [HO 1634 12-2, Schn 775/2-3]
  2. Curie Intra-European Fellowship [IEF-2009-237290]

Ask authors/readers for more resources

Disturbances of fetal autonomic brain development can be evaluated from fetal heart rate patterns (HAP) reflecting the activity of the autonomic nervous system. Although HAP analysis from cardiotocographic (GIG) recordings is established for fetal surveillance, temporal resolution is low. Fetal magnetocardiography (MCG), however, provides stable continuous recordings at a higher temporal resolution combined with a more precise heart rate variability (HRV) analysis. A direct comparison of GIG and MCG based HRV analysis is pending. The aims of the present study are: (i) to compare the fetal maturation age predicting value of the MCG based fetal Autonomic Brain Age Score (fABAS) approach with that of GIG based Dawes-Redman methodology; and (ii) to elaborate fABAS methodology by segmentation according to fetal behavioral states and HAP We investigated MCG recordings from 418 normal fetuses, aged between 21 and 40 weeks of gestation. In linear regression models we obtained an age predicting value of GIG compatible short term variability (STV) of R-2 = 0.200 (coefficient of determination) in contrast to MCG/fABAS related multivariate models with R-2 = 0.648 in 30 min recordings, R-2 = 0.610 in active sleep segments of 10 min, and R-2 = 0.626 in quiet sleep segments of 10 min. Additionally segmented analysis under particular exclusion of accelerations (AC) and decelerations (DC) in quiet sleep resulted in a novel multivariate model with R-2 = 0.706. According to our results, fMCG based fABAS may provide a promising tool for the estimation of fetal autonomic brain age. Beside other traditional and novel HRV indices as possible indicators of developmental disturbances, the establishment of a fABAS score normogram may represent a specific reference. The present results are intended to contribute to further exploration and validation using independent data sets and multicenter research structures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Psychology, Clinical

Life expectancy, mortality risks and cause of death in patients with serious mental illness in South East London: a comparison between 2008-2012 and 2013-2017

Chi-Kang Chang, Edward Chesney, Wei-Nung Teng, Sam Hollandt, Megan Pritchard, Hitesh Shetty, Robert Stewart, Philip McGuire, Rashmi Patel

Summary: This study investigates whether the mortality rate in people with serious mental illness (SMI) has changed over the last decade. The results show that, compared to the general population, individuals with SMI still have a significantly shorter life expectancy, although there appears to be some improvement. Additionally, the study finds that cancer-related mortality accounts for a similar proportion of deaths as cardiovascular disease in the 2013-2017 cohorts.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

The non-specific nature of mental health and structural brain outcomes following childhood trauma

Theresa K. Haidl, Dennis M. Hedderich, Marlene Rosen, Nathalie Kaiser, Mauro Seves, Thorsten Lichtenstein, Nora Penzel, Julian Wenzel, Lana Kambeitz-Ilankovic, Anne Ruef, David Popovic, Frauke Schultze-Lutter, Katharine Chisholm, Rachel Upthegrove, Raimo K. R. Salokangas, Christos Pantelis, Eva Meisenzahl, Stephen J. Wood, Paolo Brambilla, Stefan Borgwardt, Stephan Ruhrmann, Joseph Kambeitz, Nikolaos Koutsouleris

Summary: The study found that childhood trauma is a transdiagnostic risk factor for mental health disorders, possibly related to depressive symptoms. However, it is not possible to differentiate between different diagnosis-dependent psychopathologies, suggesting a multi-factorial pathogenesis.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study

Arsime Demjaha, Silvana Galderisi, Birthe Glenthoj, Celso Arango, Armida Mucci, Andrew Lawrence, Owen O'Daly, Matthew Kempton, Simone Ciufolini, Lone Baandrup, Bjorn H. Ebdrup, Roberto Rodriguez-Jimenez, Maria Diaz-Marsa, Covadonga Martinez Diaz-Caneja, Inge Winter van Rossum, Rene Kahn, Paola Dazzan, Philip McGuire

Summary: This study found that the orbitofrontal and temporal cortices play an important role in the pathogenesis of negative symptoms in schizophrenia. These findings were evident in generally untreated FEP patients and are unlikely to be related to effects of previous treatment or illness chronicity.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

Psychosis and substance abuse increase the COVID-19 mortality risk

Ana Catalan, Claudia Aymerich, Amaia Bilbao, Borja Pedruzo, Jose Luis Perez, Nerea Aranguren, Gonzalo Salazar de Pablo, Emily Hedges, Patxi Gil, Rafael Segarra, Ana Gonzalez-Pinto, Aranzazu Fernandez-Rivas, Lucia Inchausti, Philip McGuire, Paolo Fusar-Poli, Miguel Angel Gonzalez-Torres

Summary: COVID-19-related mortality and hospitalization rates were higher for patients with pre-existing psychotic disorders, while patients with affective disorders had lower rates.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

Cognitive bias modification for paranoia (CBM-pa): a randomised controlled feasibility study in patients with distressing paranoid beliefs

Jenny Yiend, Charlene L. M. Lam, Nora Schmidt, Bryony Crane, Margaret Heslin, Thomas Kabir, Philip McGuire, Christopher Meek, Elias Mouchlianitis, Emmanuelle Peters, Daniel Stahl, Antonella Trotta, Sukhwinder Shergill

Summary: This study investigated the feasibility and efficacy of Cognitive Bias Modification for paranoia (CBM-pa) in patients with paranoia. The results showed that CBM-pa was effective in reducing interpretation bias, improving paranoia symptoms, and reducing levels of depressed and anxious mood. The study provides a foundation for conducting a fully powered randomized controlled trial.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychiatry

Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome

Emily J. Hird, Noriyuki Ohmuro, Paul Allen, Peter Moseley, Matthew J. Kempton, Gemma Modinos, Gabriele Sachs, Mark van der Gaag, Lieuwe de Haan, Ary Gadelha, Rodrigo Bressan, Neus Barrantes-Vidal, Stephan Ruhrmann, Ana Catalan, Philip McGuire

Summary: The study found that individuals at clinical high risk for psychosis have a lower sensitivity to hearing speech in noise and uncertainty about the affective valence of this speech, which is associated with adverse clinical outcomes. The findings suggest that the ability to hear speech illusions in noise could be used as a cognitive marker to predict the likelihood of remission or transition to psychosis in individuals at risk.

SCHIZOPHRENIA BULLETIN (2023)

Article Cell Biology

Brain Macro-Structural Alterations in Aging Rats: A Longitudinal Lifetime Approach

Sidra Gull, Christian Gaser, Karl-Heinz Herrmann, Anja Urbach, Marcus Boehme, Samia Afzal, Juergen R. Reichenbach, Otto W. Witte, Silvio Schmidt

Summary: By using MRI and DBM, we examined the structural changes in the brains of male RccHan:WIST rats. The study found that the overall brain volume increased with age, but there were also divergent local morphologic alterations. The visual, auditory, and somatosensory cortical areas showed shrinkage, while the higher-order brain areas such as the ectorhinal, entorhinal, retrosplenial, and cingulate cortical regions were preserved and grew with age.

CELLS (2023)

Article Psychiatry

Therapeutic leave and direct inpatient healthcare costs in inpatients with mental illness

Tiziana Ziltener, Julian Moeller, Roselind Lieb, Undine E. Lang, Christian G. Huber

Summary: Balancing the economic costs of mental illness is a global challenge, and therapeutic leaves may be a tool to improve therapy outcomes and lower long-term mental healthcare costs. Our study found that therapeutic leaves were associated with lower healthcare costs following inpatient stays, suggesting that their use may help reduce overall healthcare costs.

JOURNAL OF PSYCHIATRIC RESEARCH (2023)

Article Neurosciences

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity

Peter Bedford, Daniel J. Hauke, Zheng Wang, Volker Roth, Monika Nagy-Huber, Friederike Holze, Laura Ley, Patrick Vizeli, Matthias E. Liechti, Stefan Borgwardt, Felix Mueller, Andreea O. Diaconescu

Summary: This study investigated the neural mechanisms of LSD using rDCM and found that LSD disrupts the excitatory/inhibitory balance of the brain. Whole-brain effective connectivity was correlated with the subjective effects of LSD and could potentially be used to decode or predict these effects in the future.

NEUROPSYCHOPHARMACOLOGY (2023)

Article Psychiatry

Semantic Speech Networks Linked to Formal Thought Disorder in Early Psychosis

Caroline R. Nettekoven, Kelly Diederen, Oscar Giles, Helen Duncan, Iain Stenson, Julianna Olah, Toni Gibbs-Dean, Nigel Collier, Petra E. Vertes, Tom J. Spencer, Sarah E. Morgan, Philip McGuire

Summary: Mapping the semantic content of speech as a network can improve our understanding of formal thought disorder in psychosis. Using the algorithm netts, we created semantic speech networks for a general population and clinical sample, finding that patients with psychosis had smaller and more fragmented networks, which were related to negative symptoms and thought and language index scores.

SCHIZOPHRENIA BULLETIN (2023)

Article Medicine, General & Internal

Differences in Selective Attention and Inhibitory Control in Patients with Major Depressive Disorder and Healthy Controls Who Do Not Engage in Sufficient Physical Activity

Markus Gerber, Robyn Cody, Johannes Beck, Serge Brand, Lars Donath, Anne Eckert, Oliver Faude, Martin Hatzinger, Christian Imboden, Jan-Niklas Kreppke, Undine E. Lang, Sarah Mans, Thorsten Mikoteit, Anja Oswald, Nina Schweinfurth-Keck, Lukas Zahner, Sebastian Ludyga

Summary: This study examined the differences in sustained attention and inhibitory control between patients with major depressive disorder (MDD) and healthy controls, as well as differences between patients with mild, moderate, and severe depression. The results showed that patients with MDD had slower reaction times in both attention and inhibitory control tasks, and younger participants had shorter reaction times. These findings suggest deficits in information processing and higher-order cognitive processes in MDD patients, which may impact in-patient treatment and contribute to the recurrent nature of depression.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biochemistry & Molecular Biology

Metabolic Fingerprints of Effective Fluoxetine Treatment in the Prefrontal Cortex of Chronically Socially Isolated Rats: Marker Candidates and Predictive Metabolites

Dragana Filipovic, Julica Inderhees, Alexandra Korda, Predrag Tadic, Markus Schwaninger, Dragos Inta, Stefan Borgwardt

Summary: The study investigated the potential markers and therapeutic effectiveness of fluoxetine in a rat model of depression induced by chronic social isolation. Metabolomics analysis identified several candidate markers for depressive behavior and fluoxetine efficacy. This approach provides a new perspective for the identification of markers and prediction of treatment outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Psychiatry

Unraveling ethnic disparities in antipsychotic prescribing among patients with psychosis: A retrospective cohort study based on electronic clinical records

Tao Wang, David Codling, Dinesh Bhugra, Yamiko Msosa, Matthew Broadbent, Rashmi Patel, Angus Roberts, Philip McGuire, Robert Stewart, Richard Dobson, Robert Harland

Summary: This study examines the current state of antipsychotic prescription with respect to patient ethnicity among a large UK mental health trust. The results show that Black patients with psychosis have a distinct pattern in antipsychotic prescription compared to White patients.

SCHIZOPHRENIA RESEARCH (2023)

Review Psychiatry

Predictors of transition in patients with clinical high risk for psychosis: an umbrella review

Christina Andreou, Sofia Eickhoff, Marco Heide, Renate de Bock, Jonas Obleser, Stefan Borgwardt

Summary: Diagnosing a clinical high-risk state can lead to timely treatment for those at risk for psychosis, resulting in better outcomes. However, only a small number of patients diagnosed with clinical high-risk will actually develop psychosis. To identify those who would benefit most from early intervention, studies have investigated predictors and biomarkers assessed at baseline. This study aimed to summarize evidence from systematic reviews and meta-analyses to determine the most consistent predictors of transition to psychosis in clinical high-risk patients.

TRANSLATIONAL PSYCHIATRY (2023)

Review Neurosciences

The Placebo Effect in Psychosis: Why It Matters and How to Measure It

Emily J. Hird, Kelly Diederen, Stefan Leucht, Karin B. Jensen, Philip Mcguire

Summary: Psychosis is often ineffective treated by antipsychotic medication, and finding an effective alternative has been challenging. The placebo effect in clinical trials makes it difficult to distinguish drug effects from placebo effects. However, a strong placebo effect in clinical practice could enhance overall treatment response. Identifying factors that predict placebo effects could improve psychosis treatment. The overlap between placebo effect and psychosis could provide new insights into the mechanisms underlying psychosis and indicate novel treatment targets.

BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE (2023)

No Data Available